Large pharmaceutical companies are turning to AI more frequently, despite some challenges. This and more in this week’s update. … READ MORE >
Health care
NIH adopts new policy for funding research
In the end, this policy choice will increase costs and inherently reduce the amount of money available for actual research. … READ MORE >
5 things to know in life sciences: Week of Feb. 3, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Jan. 27, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Jan. 20, 2025
What trends are being driven by artificial intelligence in medtech? We explore this issue and others in this week’s five things affecting the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of Jan. 13, 2025
J.P. Morgan Healthcare Conference highlights and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Jan. 6, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Dec. 16, 2024
Manufacturing takes center stage in biopharma. This and more in this week’s life sciences update. … READ MORE >
Tariff discussions in health care and life sciences industries stoke global supply chain concerns
The health care and life sciences industries could be facing significant changes under a second Trump administration. From the prospect of new tariffs to the likelihood that the BIOSECURE Act will be enacted, companies are scrambling to adjust to what could be a changed operating environment. Already, the prospect of … … READ MORE >
5 things to know in life sciences: Week of December 9, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump’s nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift toward a more business-friendly antitrust approach, focusing on … … READ MORE >